Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials. - Wikidata - wikimedia - TriplyDB

Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials.

Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials.

http://www.wikidata.org/entity/Q30411811

about

Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience.Radiation therapy quality assurance in clinical trials--Global Harmonisation Group A phase-I trial of pre-operative, margin intensive, stereotactic body radiation therapy for pancreatic cancer: the 'SPARC' trial protocol.Prospective review of radiotherapy trials through implementation of standardized multicentre workflow and IT infrastructure Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The dummy run.Technical quality assurance during the TROG 03.04 RADAR prostate radiotherapy trial: are the results reflected in observed toxicity rates?

P2860

Q34667324-1C3FA5C1-F004-4842-93CA-589FCC038665 Q34815954-4210ACD5-3374-40D4-A285-8B464B45973E Q36130588-66A287FB-69EE-4FF0-BF59-A750F0B021C2 Q38380009-E8E97D5A-D492-4D0C-8FFD-BFFBB868DD84 Q38728358-C294B08A-0257-4586-804F-1C1C4175B808 Q43615997-A9C2833D-E622-4724-BD2B-3C25E6805123

P2860

Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials.

http://www.wikidata.org/entity/Q30411811

description

2012 nî lūn-bûn

@nan

2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Compliance with therapeutic gu ...... trointestinal clinical trials.

@ast

Compliance with therapeutic gu ...... trointestinal clinical trials.

@en

type

label

Compliance with therapeutic gu ...... trointestinal clinical trials.

@ast

Compliance with therapeutic gu ...... trointestinal clinical trials.

@en

prefLabel

Compliance with therapeutic gu ...... trointestinal clinical trials.

@ast

Compliance with therapeutic gu ...... trointestinal clinical trials.

@en

P1433

Q30411811-8E877B0B-D3DF-414F-B614-91E5604AA8FA

P1476

Q30411811-E80E5D08-0DAB-443D-81C0-F61EF8F2A9EE

P2093

Q30411811-23EC2D24-8E77-4498-85E6-19E2DA01633F

Q30411811-26BBF50F-46ED-4507-9EC6-2FDCDE599BF4

Q30411811-3A052278-1901-4914-8075-BD6971DD5397

Q30411811-5C6143AA-27E6-40B2-A8B5-6B939211D73C

Q30411811-689C9022-7373-4D54-A584-B027F722583F

Q30411811-742F220E-9765-4E5A-9547-E5BF382B1B74

Q30411811-D007D900-5C50-4E1A-863C-4DE18AD06964

Q30411811-ED48B474-157D-4BA8-9054-D80B301185B7

Q30411811-F2167F36-88F5-4313-97DE-63C9857F60A5

Q30411811-F69599C0-7637-4584-94D1-63AB5E7F0EFD

P2860

Q30411811-04378D71-7812-4435-9BD9-09682ADDA31B

Q30411811-074E56D0-E710-4D12-BE7E-D5C7AED5E680

Q30411811-11305283-1881-4C24-BC21-B2E26C8D0A18

Q30411811-17932597-23BB-497B-972F-48A706E81A52

Q30411811-19A69FAB-0F32-4416-B5F2-AE55234F9345

Q30411811-223E2521-DC6B-4C9E-B5D2-AFF12348F0F7

Q30411811-2CBEE454-29F3-4154-B710-6BD72B35575D

Q30411811-2FEF306E-66F1-445B-866F-6AD318D117F4

Q30411811-31D8FA7E-E459-4718-97CA-EB1EBE4E0FDA

Q30411811-3782A651-D6AB-4583-B15B-C3666C764C41

P304

Q30411811-8ECAD1C7-D7B0-4BEC-9FDC-41AD0FB13909

P31

Q30411811-AC84F02E-F3A4-4D40-B38D-DAF114699E7F

P356

Q30411811-11F0F7C5-226D-4535-B200-4CB0CC1B4B1D

P433

Q30411811-14FAE415-A261-42ED-B724-C2000DA191EF

P478

Q30411811-73066A43-DD27-4D94-A987-D744A9912324

P50

Q30411811-5508AFEC-82CC-4BA9-A3F0-1EF56D48D224

P577

Q30411811-EEA30CCA-B3D6-4DC6-B69E-311B0908560A

P698

Q30411811-8CC27B2A-804E-4584-AC2C-9FC81A2DA131

P921

Q30411811-D7D59230-D21F-40F2-8A14-A3B92A8C6AB5

P932

Q30411811-48AE8FB2-A27C-4159-BE89-167D390EF880

P356

J.RADONC.2012.09.011

P1433

Radiotherapy and Oncology

P1476

Compliance with therapeutic gu ...... trointestinal clinical trials.

@en

P2093

Christopher G Willett

http://www.w3.org/2001/XMLSchema#string

Christopher H Crane

http://www.w3.org/2001/XMLSchema#string

Denise Manfredi

http://www.w3.org/2001/XMLSchema#string

Elizabeth O'Meara

http://www.w3.org/2001/XMLSchema#string

James M Galvin

http://www.w3.org/2001/XMLSchema#string

Jennifer Moughan

http://www.w3.org/2001/XMLSchema#string

Kathryn Winter

http://www.w3.org/2001/XMLSchema#string

Rachel Rabinovitch

http://www.w3.org/2001/XMLSchema#string

Robert Lustig

http://www.w3.org/2001/XMLSchema#string

Tyvin A Rich

http://www.w3.org/2001/XMLSchema#string

P2860

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas.

Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer

Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12.

Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal

Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.

An evaluation of the relationship between the quality of prophylactic cranial radiotherapy in childhood acute leukemia and institutional experience: a Quality Assurance Review Center-Pediatric Oncology Group study.

Quality assurance in the EORTC 22921 trial on preoperative radiotherapy with or without chemotherapy for resectable rectal cancer: evaluation of the individual case review procedure.

Quality assurance of EORTC trial 22922/10925 investigating the role of internal mammary--medial supraclavicular irradiation in stage I-III breast cancer: the individual case review.

P304

9-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.RADONC.2012.09.011

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

Mitchell Machtay

P577

2012-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23084596

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

4106147

http://www.w3.org/2001/XMLSchema#string